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Education of patients in regular self-examination of their 
breasts cannot be overemphasised. Furthermore, doctors 
should be strongly encouraged to include an examination of the 
breasts as part of a general medical examination.
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CLINICAL IMAGES
Progressive multifocal leucoencephalopathy – a case report
Mala Modi
Progressive multifocal leucoencephalopathy (PML) is a 
demyelinating disease caused by the human neurotropic JC 
(John Cunningham) virus, a polyomavirus.1,2 
Following on the worldwide HIV/AIDS pandemic there has 
been a dramatic increase in the incidence of PML. However, 
cases of PML, an AIDS-defining illness, have rarely been 
reported from Africa, an area where HIV-1 clade C infection 
predominates.3-5 
Clinical and imaging details
A 27-year-old woman presented to Chris Hani Baragwanath 
Hospital, Johannesburg, with new-onset seizures. She was 
heterosexual, did not abuse intravenous drugs, and was 
retroviral therapy-naïve. On examination in the medical ward 
she was found to be encephalopathic and pregnant. Further 
investigations revealed that she was HIV-positive with a very 
low CD4+ count of 7 cells/µl, and a viral load greater than  
750 000 copies/ml. She was referred for imaging, and PML 
was diagnosed on the basis of computed tomography (CT) and 
magnetic resonance imaging (MRI) appearances. 
The lesions on CT imaging were typical; they were scalloped 
in appearance, involved the white matter of the frontal, parietal 
Fig. 1. Axial CT scan of the brain showing deep white-matter hypodensity 
involving predominantly the right parieto-occipital lobes. There is no mass 
effect.
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and occipital lobes, were hypodense, had no mass effect, 
and were non-enhancing (Fig. 1). On MRI the lesions were 
hypointense on T1 and hyperintense on T2-weighted MRI scans 
(Fig. 2, a and b).
The very low CD4+ count of 7 contributed to the diagnosis 
of PML. The diagnosis was confirmed on polymerase chain 
reaction (PCR) identification of the JC virus.
The patient died in hospital within a few days, and the 
diagnosis of PML was confirmed at autopsy.  
Discussion
This is a rare case of autopsy-proven PML from a clade C  
HIV-1 infected area.6 It is pertinent to highlight this 
demyelinating opportunistic viral infection as access to 
antiretroviral therapy is currently improving, and the immune 
reconstitution inflammatory syndrome (IRIS) that occasionally 
results following the initiation of highly active antiretroviral 
therapy (HAART) may in rare instances induce a paradoxical 
clinical deterioration in patients suffering from PML.7 It 
has been documented that HAART-induced paradoxical 
aggravation of AIDS-related PML due to IRIS is reversible in 
most cases with the use of prolonged steroid therapy.7,8 
Imaging can be particularly helpful when managing patients 
with PML and IRIS. PML lesions in patients not on HAART 
generally do not enhance, while in patients with IRIS contrast 
enhancement of the lesions may be seen.7
It therefore behoves us to be more vigilant when managing 
our patients with PML on HAART, as the early diagnosis and 
timely management of IRIS is critical.8
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Fig. 2, a and b. T2 axial and sagittal MR images demonstrating extensive 
white-matter hyperintensities involving the frontal, parieto-occipital, and 
temporal lobes. There is background cerebral atrophy typical of advanced 
retroviral disease.
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